{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:18:25Z","timestamp":1792189105362,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ejogrb.2022.01.013","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T11:19:11Z","timestamp":1642418351000},"page":"176-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Preoperative clinical characteristics between uterine sarcoma and leiomyoma in patients with uterine mass, a case-control study"],"prefix":"10.1016","volume":"270","author":[{"given":"Panlada","family":"Chantasartrassamee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chompunoot","family":"Kongsawatvorakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naparat","family":"Rermluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuenkamon","family":"Charakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujira","family":"Wattanayingcharoenchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arb-aroon","family":"Lertkhachonsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.ejogrb.2022.01.013_b0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ijgo.12613","article-title":"Uterine sarcomas","volume":"143","author":"Mbatani","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.01.013_b0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: a review","volume":"116","author":"D'Angelo","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.01.013_b0015","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/0284186X.2012.689111","article-title":"Diagnosis and treatment of sarcoma of the uterus. A review","volume":"51","author":"Trop\u00e9","year":"2012","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.01.013_b0020","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/PGP.0b013e318200caff","article-title":"Diagnostic immunohistochemistry in uterine sarcomas: a study of 397 cases","volume":"30","author":"Abeler","year":"2011","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.01.013_b0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygyno.2017.02.012","article-title":"Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study","volume":"145","author":"Seagle","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.01.013_b0030","doi-asserted-by":"crossref","first-page":"179.e1","DOI":"10.1016\/j.ajog.2018.11.1086","article-title":"Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study","volume":"220","author":"Multinu","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.01.013_b0035","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/ijgc-00009577-200207000-00005","article-title":"Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus","volume":"12","author":"Goto","year":"2002","journal-title":"Int J Gynecol Cancer"},{"issue":"6s","key":"10.1016\/j.ejogrb.2022.01.013_b0040","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jmig.2015.08.012","article-title":"Rates of minimally invasive hysterectomy and myomectomy decrease after the FDA warning on power morcellation","volume":"22","author":"Barron","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.01.013_b0045","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ygyno.2014.11.018","article-title":"Incidental power morcellation of malignancy: a retrospective cohort study","volume":"136","author":"Graebe","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.01.013_b0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/AOG.0000000000001187","article-title":"Occult uterine sarcoma and leiomyosarcoma: incidence of and survival associated with morcellation","volume":"127","author":"Raine-Bennett","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.01.013_b0055","doi-asserted-by":"crossref","first-page":"259.e1","DOI":"10.1016\/j.ajog.2016.11.1039","article-title":"Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroids: an updated decision analysis following the 2014 Food and Drug Administration safety communications","volume":"216","author":"Siedhoff","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.01.013_b0060","doi-asserted-by":"crossref","first-page":"591.e1","DOI":"10.1016\/j.ajog.2015.03.006","article-title":"Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroid tumors in premenopausal women: a decision analysis","volume":"212","author":"Siedhoff","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.01.013_b0065","doi-asserted-by":"crossref","DOI":"10.1186\/2193-1801-3-678","article-title":"Novel uterine sarcoma preoperative diagnosis score predicts the need for surgery in patients presenting with a uterine mass","volume":"3","author":"Nagai","year":"2014","journal-title":"Springerplus"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.01.013_b0070","article-title":"Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.01.013_b0075","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/IGC.0000000000000940","article-title":"Characterization and preoperative risk analysis of leiomyosarcomas at a high-volume tertiary care center","volume":"27","author":"Peters","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.01.013_b0080","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/IGC.0000000000000968","article-title":"Undiagnosed uterine sarcomas identified during surgery for presumed leiomyoma at a national tertiary hospital in Thailand: A 10-year review","volume":"27","author":"Ruengkhachorn","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"10.1016\/j.ejogrb.2022.01.013_b0085","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/aogs.12930","article-title":"Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study","volume":"95","author":"Skorstad","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.01.013_b0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00404-018-4949-4","article-title":"Incidence and groups at risk for unexpected uterine leiomyosarcoma: a Dutch nationwide cohort study","volume":"299","author":"van den Haak","year":"2019","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.01.013_b0095","article-title":"Clinical characteristics differentiating uterine sarcoma and fibroids","volume":"22","author":"Chen","year":"2018","journal-title":"Jsls. Jan-Mar"},{"issue":"10","key":"10.1016\/j.ejogrb.2022.01.013_b0100","article-title":"Developing a preoperative algorithm for the diagnosis of uterine leiomyosarcoma","volume":"10","author":"Lawlor","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"8","key":"10.1016\/j.ejogrb.2022.01.013_b0105","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jogc.2017.03.090","article-title":"A multicentre retrospective review of clinical characteristics of uterine sarcoma","volume":"39","author":"Wais","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.01.013_b0110","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.bpobgyn.2011.07.002","article-title":"Clinical presentation and diagnosis of uterine sarcoma, including imaging","volume":"25","author":"Wu","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.01.013_b0115","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/AOG.0000000000001242","article-title":"Risk of occult uterine sarcoma in women undergoing hysterectomy for benign indications","volume":"127","author":"Kho","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.01.013_b0120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jmig.2015.07.017","article-title":"Risk factors for occult uterine sarcoma among women undergoing minimally invasive gynecologic surgery","volume":"23","author":"Oduyebo","year":"2016","journal-title":"J Minim Invasive Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.01.013_b0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2008.02.026","article-title":"The utility of preoperative endometrial sampling for the detection of uterine sarcomas","volume":"110","author":"Bansal","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.01.013_b0130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jmig.2016.01.022","article-title":"The role of endometrial biopsy in the preoperative detection of uterine leiomyosarcoma","volume":"23","author":"Hinchcliff","year":"2016","journal-title":"J Minim Invasive Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.01.013_b0135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00004347-199507000-00008","article-title":"Clinicopathologic study of 28 uterine leiomyosarcomas with metastasis","volume":"14","author":"Jones","year":"1995","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.01.013_b0140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.AOG.0000150453.10906.b6","article-title":"Uterine myomas: An overview of development, clinical features, and management","volume":"105","author":"Parker","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.01.013_b0145","first-page":"129","article-title":"Uterine sarcoma: a report of 57 cases over a 16-year period analysis","volume":"29","author":"Tsikouras","year":"2008","journal-title":"Eur J Gynaecol Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.01.013_b0150","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/IGC.0000000000000189","article-title":"Preoperative ultrasound-guided needle biopsy of 63 uterine tumors having high signal intensity upon T2-weighted magnetic resonance imaging","volume":"24","author":"Tamura","year":"2014","journal-title":"Int J Gynecol Cancer"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211522000215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211522000215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:57:19Z","timestamp":1759557439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211522000215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":30,"alternative-id":["S0301211522000215"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2022.01.013","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative clinical characteristics between uterine sarcoma and leiomyoma in patients with uterine mass, a case-control study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2022.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}